GALWAY, IRELAND--February 9, 2021--Written by Martin Lynch, European News
Editor for Industrial Info (Galway, Ireland)--The Pfizer/BioNTech duo has completed the manufacturing upgrades needed to overcome recent European delays in the production of its COVID-19 vaccine and has promised an extra 75 million doses by Spring.
Within this article: Details production upgrades for extra vaccine rollout, plants, deals with rivals to boost production
This Premium Article can be purchased individually or as part of a subscription
Articles related to this company
Toll Free: +1 800 762 3361
Phone: +1 713 783 5147
Fax: +1 713 266 9306